Reference health
A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases
48/48 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
The 48 checked references that resolve
resolves10.1038/nrrheum.2015.167
Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases
resolves10.1155/2009/979258
Cytokines and Cytokine Profiles in Human Autoimmune Diseases and Animal Models of Autoimmunity
resolves10.1136/annrheumdis-2011-201024
Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway
resolves10.1136/annrheumdis-2016-209668
Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial
resolves10.1002/art.39962
Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus
resolves10.1038/nm.2130
A CD8+ T cell transcription signature predicts prognosis in autoimmune disease
resolves10.1038/82717
Reciprocal regulation of polarized cytokine production by effector B and T cells
resolves10.7554/eLife.41641
IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation
resolves10.1016/j.immuni.2018.08.015
Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus
resolves10.1126/scitranslmed.aab4176
Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
resolves10.1002/art.40390
Association of Defective Regulation of Autoreactive Interleukin‐6–Producing Transitional B Lymphocytes With Disease in Patients With Systemic Sclerosis
resolves10.1111/sji.12792
CD21<sup>−/low</sup> B cells associate with joint damage in rheumatoid arthritis patients
resolves10.4049/jimmunol.1100885
B Cell-Derived IL-15 Enhances CD8 T Cell Cytotoxicity and Is Increased in Multiple Sclerosis Patients
resolves10.1126/sciadv.aas9944
BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance
resolves10.1038/s41467-018-03750-7
IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE
resolves10.1172/jci.insight.139032
Pathogenic, glycolytic PD-1+ B cells accumulate in the hypoxic RA joint
resolves10.1038/nrrheum.2017.220
Moving towards a molecular taxonomy of autoimmune rheumatic diseases
resolves10.1002/art.34473
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
resolves10.1136/ard.61.6.554
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
resolves10.1002/art.38098
2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
resolves10.1002/art.27584
2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
resolves10.1002/art.22224
Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: Association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual
resolves10.1038/nbt.2594
viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia
resolves10.1006/cyto.2000.0757
SERUM LEVELS OF IFN-INDUCIBLE PROTEIN-10 RELATING TO THE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS
resolves10.3389/fimmu.2019.01535
IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function
resolves10.1084/jem.20170580
B cell–derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity
resolves10.1038/s41590-018-0056-8
Regulation of age-associated B cells by IRF5 in systemic autoimmunity
resolves10.1016/j.jaci.2016.01.024
Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation
resolves10.1136/annrheumdis-2019-215894
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile
resolves10.1038/s41590-019-0378-1
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
resolves10.1073/pnas.1905301116
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology
resolves10.1016/j.jid.2016.11.037
Skin-Resident Effector Memory CD8+CD28– T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic Sclerosis
resolves10.1038/s41590-020-00814-z
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19
resolves10.1016/j.immuni.2017.05.005
The Transcription Factor T-bet Limits Amplification of Type I IFN Transcriptome and Circuitry in T Helper 1 Cells
resolves10.1016/j.immuni.2012.10.010
Interferon-γ Excess Leads to Pathogenic Accumulation of Follicular Helper T Cells and Germinal Centers
resolves10.1038/nature11501
Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
resolves10.1111/imr.12374
Cytokine‐producing B cells: a translational view on their roles in human and mouse autoimmune diseases
resolves10.1182/blood-2014-09-599159
CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease
resolves10.1002/art.38734
Primary Sjögren's Syndrome Is Characterized by Distinct Phenotypic and Transcriptional Profiles of IgD+ Unswitched Memory B Cells
resolves10.3899/jrheum.171361
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1002/art.41697"><img src="https://citestamp.com/citestamped/10.1002/art.41697/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1002/art.41697)